Investigation of a reaction path between platinum(IV) nitrogen mustard hybrid drug and DNA-guanine by B3LYP-SDD/DFT method
Keywords:
nitrogen mustards, gaussian, DNA-guanine, SN2 reactionAbstract
This research investigated the nucleophilic substitution mechanism of cyclophosphamide and platinum(IV) nitrogen mustard with DNA-guanine(s) by calculating equilibrium constant and thermodynamic parameters such as enthalpy, entropy, and Gibbs free energy using Gaussian software with B3LYP-SDD/DFT method. The calculations aimed to predict the SN2 reaction pathway through quantum chemical analysis, which no researches had investigated. This research had proved the calculation on cyclophosphamide was correct in computational values with previous researched experiments. So that, successfully drawing a recommended reaction path for platinum(IV) nitrogen mustard with DNA-guanine(s) by choosing the best reaction in four phases which based on favorable thermodynamic parameters and equilibrium constant. The IR and 13C-NMR spectra are consistent with the experimental results. The negative Gibbs free energy value in the reaction between platinum(IV) nitrogen mustard and DNA indicates good reactivity and the ability to inhibit the growth of cancer cells. Overall, the study successfully elucidated the nucleophilic substitution mechanism of platinum(IV) nitrogen mustard and cyclophosphamide with DNA-guanine(s). Platinum(IV) nitrogen could be used to treat cancer as same as cyclophosphamide.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 INTERNATIONAL RESEARCH JOURNAL OF CHEMISTRY

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article
- The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (IRJC).

